Clinical trial Recruiting at 1 site Observational Ages 16 Weeks to 28 Weeks

Predicting postnatal circulation in pulmonary atresia with intact ventricular septum

Official title: Development and Validation of a Prognostic Model of Postnatal Circulation in Fetuses With a Diagnosis of Pulmonary Atresia-critical Stenosis With Intact Ventricular Septum A Prospective Observational Cohort Study

Run by Hospital Universitario 12 de Octubre · NCT07095829 · Data updated 2026-11-12

This project will try to use fetal ultrasound measurements to see if doctors can predict which babies with pulmonary atresia and an intact ventricular septum will have a biventricular/one-and-a-half repair versus need univentricular palliation by age 2.

Quick facts

Study typeObservational
Ages16 Weeks to 28 Weeks
SexAll
Enrollment150 (estimated)
SponsorHospital Universitario 12 de Octubre
Academic / other
Locations2 sites (Madrid and 1 other locations)
StatusRecruiting
StartedFebruary 1, 2024
Main results expectedFebruary 1, 2028
Study endsDecember 31, 2029
Registry record updatedSeptember 15, 2025
Trial IDNCT07095829 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are fetuses diagnosed at a participating referral center between 16+0 and 28+6 weeks with pulmonary atresia or critical pulmonary stenosis and an intact ventricular septum, without major extracardiac anomalies or known genetic syndromes, and who did not undergo prenatal pulmonary valvuloplasty.

Probably not a fit

Patients who had prenatal pulmonary valvuloplasty, terminated pregnancies, poor-quality or incomplete imaging, postnatally unconfirmed diagnoses, or significant associated cardiac or extracardiac anomalies are unlikely to benefit from or be included in the predictive model.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is an international observational cohort that combines retrospective cases (2013–2023) with a prospective validation cohort to develop a prenatal prognostic model. Non-intervened fetuses diagnosed between 16+0 and 28+6 weeks with PA/CS-IVS will be included and baseline and follow-up fetal echocardiograms plus the first postnatal echo will be collected. All echocardiographic studies will be reviewed centrally by a core laboratory to confirm eligibility and standardize measurements. The primary outcome is transplantation-free survival with a biventricular or one-and-a-half repair at 2 years versus univentricular palliation or transplantation, and the study will also model risk of right-ventricle-dependent coronary circulation.

Why it matters

Potential benefit: If successful, the model could give families and clinicians clearer prenatal prognoses to guide counseling, delivery planning, and early postnatal management.

How similar studies have gone: There are single-center reports and surgical series describing outcomes and some predictors, but comprehensive, externally validated prenatal models for predicting univentricular versus biventricular circulation in PA/CS-IVS remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Absence of flow at the pulmonary valve (PA) or presence of thickened and domed. pulmonary valve cusps with a pinhole jet of flow.
* Doppler evidence of ductal-dependent pulmonary circulation.
* Intact ventricular septum.

Exclusion Criteria:

* Poor imaging windows and incomplete/poor quality scan
* Termination of pregnancy
* Cases initially included that undergo prenatal pulmonary valvuloplasty later on in pregnancy.
* Unconfirmed PA-CS/IVS at birth.
* Functional PA-CS/IVS (Ebstein malformation, monochorionic twins)
* Any associated cardiac defect except persistent left superior vena cava and aberrant right subclavian artery.
* Any significant (i.e that might influence outcome) extracardiac anomaly and/or known genetic syndromes. Also, if such a condition is present at inclusion but diagnosed only after birth, the case will be retrospectively excluded.

Where it's running

  • Hospital Universitario 12 de Octubre
    Madrid, Spain
    Recruiting
  • University of Gothenburg
    Gothenburg, Sweden
    Active not recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.